NHS Doctor Accuses Tribunal of Bias in Antisemitism Case

An NHS doctor, Dr. Rahmeh Aladwan, has raised allegations of bias against a medical tribunal panel after it declined to suspend proceedings regarding her conduct. The General Medical Council (GMC) is investigating Dr. Aladwan for purported antisemitic and pro-Hamas statements made on her social media, following concerns about her fitness to practice medicine.

Dr. Aladwan, a 31-year-old British-Palestinian trainee trauma and orthopaedic surgeon, appeared at the Medical Practitioners Tribunal Service (MPTS) in Manchester. She wore a distinctive gold necklace adorned with a “number seven” charm, which she previously described as “celebratory jewellery.” The interim orders tribunal (IOT) convened for three days to assess whether any restrictions should be imposed on her medical registration while the investigation is ongoing.

The controversy intensified following Dr. Aladwan’s social media posts, particularly those made on October 7, 2023. In one post, she stated, “The day Israel was humiliated. Their supremacy shattered at the hands of the children they forced out of their homes,” and likened Israelis to “worse than Nazis.” These comments have sparked significant public and political backlash.

In a previous IOT hearing in September, the panel decided against placing restrictions on Dr. Aladwan, concluding that the complaints did not indicate a real risk to patient safety. Health Secretary Wes Streeting condemned her remarks, asserting that “sickening comments” are unacceptable within the NHS, and announced intentions to reform how medical regulators handle allegations of antisemitism.

The GMC subsequently re-referred Dr. Aladwan’s case back to the MPTS, leading to the current proceedings. During today’s hearing, the defense counsel, Kevin Saunders, claimed that the GMC had engaged in an “abuse of process” and argued against the fairness of the tribunal. He requested the panel to be recused, citing “apparent bias” due to external influences, including the involvement of civil lobby groups and ministerial intervention.

Dr. Aladwan’s defense emphasized the need for transparency and fairness, especially given the high-profile nature of the case. “This is a case that has attracted the intervention of a minister of state and civil lobby groups,” Saunders stated, insisting that the tribunal’s decision-making process must remain objective.

In response, Emma Gilsenan, representing the GMC, argued that the defense was attempting to revisit previously settled issues. She asserted that the prior tribunal’s findings were well-reasoned and that there was no evidence of bias. Gilsenan highlighted that recent online posts by Dr. Aladwan exhibited an increase in inflammatory rhetoric, which she argued warranted careful scrutiny.

The tribunal ultimately rejected the application for recusal, and an additional request for an adjournment was also denied. Dr. Aladwan expressed a desire to participate fully in the proceedings, but issues regarding her attendance remain unresolved.

If the GMC concludes that Dr. Aladwan has a case to answer, she could face a full medical practitioners’ tribunal. The outcome of this case may have significant implications for the standards of conduct expected from medical professionals, particularly in relation to social media discourse surrounding sensitive political issues.